1) D'Amico AV, et al : Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer. JAMA 280 : 969-974, 1998
2) Fujii Y, et al : Molecular Classification and Diagnostics of Upper Urinary Tract Urothelial Carcinoma. Cancer Cell 39 : 793-809, 2021
3) Perou CM, et al : Molecular Portraits of Human Breast Tumours. Nature 406, 747-752, 2000
4) Suzuki H, et al : Mutational Landscape and Clonal Architecture in Grade II and III Gliomas. Nat Genet 47 : 458-468, 2015
5) Robertson AG, et al : Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 171 : 540-556 e525, 2017
6) Choi W, et al : Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy. Cancer Cell 25 : 152-165, 2014
7) Kamoun A, et al : A Consensus Molecular Classification of Muscle-Invasive Bladder Cancer. Eur Urol 77 : 420-433, 2020
8) Hedegaard J, et al : Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma. Cancer Cell 30, 27-42, 2016
9) Sjodahl G, et al : A Molecular Taxonomy for Urothelial Carcinoma. Clin Cancer Res 18 : 3377-3386, 2012
10) Le DT, et al : PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med 372 : 2509-2520, 2015
11) Canon J, et al : The Clinical KRAS (G12C) Inhibitor AMG 510 Drives Anti-Tumour Immunity. Nature 575 : 217-223, 2019
12) Messer J, et al : Urinary Cytology Has a Poor Performance for Predicting Invasive or High-Grade Upper-Tract Urothelial Carcinoma. BJU Int 108 : 701-705, 2011
13) Tanaka N, et al : The Predictive Value of Positive Urine Cytology for Outcomes Following Radical Nephroureterectomy in Patients with Primary Upper Tract Urothelial Carcinoma : A Multi-Institutional Study. Urol Oncol 32 : 48, 2014
14) Roupret M, et al : European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma : 2017 Update. Eur Urol 73 : 111-122, 2018
15) Shiraishi Y, et al : A Comprehensive Characterization of Cis-Acting Splicing-Associated Variants in Human Cancer. Genome Res 28 : 1111-1125, 2018